  | Khellaf, L., Lemiale, V., Decavèle, M., de Chambrun, M. P., Beurton, A., Kamel, T., Stoclin, A., Mokart, D., Bruneel, F., Vigneron, C., Kouatchet, A., Henry, B., Quenot, J.-P., Jolly, G., Issa, N., Bellal, M., Poissy, J., Pichereau, C., Schmidt, J., ... Joseph, A. (February 2024). Critically Ill Patients with Visceral Nocardia Infection, France and Belgium, 2004-2023. Emerging Infectious Diseases, 30 (2), 345 - 349. doi:10.3201/eid3002.231440  Peer Reviewed verified by ORBi |
 | Peetermans, M.* , Matheeussen, V.* , Moerman, C., De Rydt, F., Thieren, S., Pollet, E., Casaer, M., De Backer, B., De Paep, R., Debaveye, Y., Desmet, L., Desmet, S., Duval, E. I. M., Fraipont, V., Geysels, D., Hermans, G., Lahaye, F., Mathy, X., Meersseman, P., ... Jorens, P. G.*. (29 January 2024). Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series. Annals of Intensive Care, 14 (1), 19. doi:10.1186/s13613-024-01249-7 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Fontaine, C., Layios, N., Giot, J.-B., Meex, C., & Descy, J. (January 2024). Un antibiogramme rapide optimise-t-il la prise en charge thérapeutique des patients présentant une bactériémie ? Revue Médicale de Liège, 79 (1), 17-22. Editorial Reviewed verified by ORBi |
 | Gosset, C., Foguenne, J., SIMUL, M., Layios, N., Massion, P., DAMAS, P., & Gothot, A. (2024). A reactive monocyte subset characterized by low expression of CD91 is expanded during sterile and septic inflammation. Clinical Chemistry and Laboratory Medicine, 1-12. doi:10.1515/cclm-2023-0992 Peer Reviewed verified by ORBi |
 | Misset, B., Piagnerelli, M., Hoste, E., Dardenne, N., Grimaldi, D., Michaux, I., De Waele, E., Dumoulin, A., Jorens, P. G., van der Hauwaert, E., Vallot, F., Lamote, S., Swinnen, W., De Schryver, N., Fraipont, V., de Mey, N., Dauby, N., Layios, N., Mesland, J.-B., ... Laterre, P.-F. (26 October 2023). Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients. New England Journal of Medicine, 389 (17), 1590-1600. doi:10.1056/nejmoa2209502 Peer Reviewed verified by ORBi |
 | Misset, B., Nguyet, A. D., BERTRAND, A., Piagnerelli, M., Hoste, E., de Waele, E., Dumoulin, A., Jorens, P., van der Hauwaert, E., Vallot, F., Swinnen, W., De Schryver, N., de Mey, N., Layios, N., Mesland, J., Robinet, S., Cavalier, E., Donneau, A.-F., Moutschen, M., & Laterre, P. F. (24 October 2023). Immunological sub-phenotypes and response to Convalescent-Plasma (CP) in COVID-19 induced ARDS (C-ARDS): a hierarchical cluster analysis [Poster presentation]. ESICM LIVES 2023, Milan, Italy. Peer reviewed |
 | Hendrikx, E., Mathieu, D., Mathy, X., Fraipont, V., Misset, B., Meex, C., & Layios, N. (16 June 2023). A Multicenter Case Series of invasive Streptococcus pyogenes A (GAS) Infections from a Tertiary ICU in Liège, Belgium [Poster presentation]. Belgian Society of Intensive Care Medicine annual meeting, Bruxelles, Belgium. Editorial reviewed |
 | Misset, B., Piagnerelli, M., Hoste, E., Dardenne, N., Grimaldi, D., Michaux, I., De Waele, E., Dumoulin, A., Jorens, P., Layios, N., Moutschen, M., Desmecht, D., Gothot, A., & Laterre, P. F. (14 June 2023). Proceedings of Reanimation 2023, the French Intensive Care Society International CongressCO‐59 Secondary outcomes of the CONFIDENT randomized trial of convalescent plasma therapy with high titers of neutralizing antibodies (NAb) in COVID-ARDS patients [Poster presentation]. SRLF annual meeting 2023, Paris, France. doi:10.1186/s13613-023-01131-y Peer reviewed |
 | Layios, N., Mathieu, D., Dumont, R., & GILLARD, R. (2023). Fulminant hepatic failure: An unusual suspect. JACEP: Journal of the American College of Emergency Physicians. doi:10.1002/emp2.12912 Peer Reviewed verified by ORBi |
 | Tabah, A., Buetti, N., Staiquly, Q., Ruckly, S., Akova, M., Aslan, A. T., Leone, M., Conway Morris, A., Bassetti, M., Arvaniti, K., Lipman, J., Ferrer, R., Qiu, H., Paiva, J.-A., Povoa, P., De Bus, L., De Waele, J., Zand, F., Gurjar, M., ... Layios, N. (Other coll.). (February 2023). Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Medicine, 49 (2), 178 - 190. doi:10.1007/s00134-022-06944-2 Peer Reviewed verified by ORBi |
 | Layios, N., Gosset, C., Maes, N., Delierneux, C., Hego, A., Huart, J., LECUT, C., DAMAS, P., Oury, C., & Gothot, A. (2023). Prospective flow cytometry analysis of leucocyte subsets in critically ill patients who develop sepsis: a pilot study. Infection. doi:10.1007/s15010-023-01983-3 Peer Reviewed verified by ORBi |
 | Layios, N. (2022). Streamlining antimicrobial stewardship tools in critically ill patients [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/299325 |
 | De Voeght, A., WILLEMS, E., Servais, S., Seidel, L., Pirotte, M., Massion, P., Layios, N., Pereira, M., Misset, B., CANIVET, J.-L., Beguin, Y., & Baron, F. (31 August 2022). Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores. Cancers, 14 (17), 4266. doi:10.3390/cancers14174266 Peer Reviewed verified by ORBi |
 | GREGOIRE, C.* , LAYIOS, N.* , LAMBERMONT, B., LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., THYS, M., Dardenne, N., Misset, B.* , & BEGUIN, Y.*. (04 July 2022). Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial. Frontiers in Immunology, 13, 932360. doi:10.3389/fimmu.2022.932360 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Robba, C., Giovannini, M., Meyfroidt, G., van der Jagt, M., Citerio, G., Smith, M., & Layios, N. (Other coll.). (01 July 2022). Intensive Care Admission and Management of Patients With Acute Ischemic Stroke: A Cross-sectional Survey of the European Society of Intensive Care Medicine. Journal of Neurosurgical Anesthesiology, 34 (3), 313 - 320. doi:10.1097/ANA.0000000000000761 Peer Reviewed verified by ORBi |
 | Misset, B., Piagnerelli Michaël, Hoste Eric, Dardenne, N., Grimaldi D., Michaux, I., Dumoulin, A., Jorens, P., van der Hauwaert, E., de Waele, E., Vallot, F., Lamote, S., Swinnen, W., Fraipont, V., de Mey, N., de Schryver, N., de Wit, S., Layios, N., Mesland, J., ... Laterre, P. F. (June 2022). Convalescent plasma therapy with high titers of neutralizing antibodies to reduce mortality in patients with COVID-19 associated ARDS: the Belgian randomized CONFIDENT trial [Poster presentation]. SIZ Annual Meeting, Bruxelles, Belgium. Peer reviewed |
  | Misset, B., Parzibut, G., LAYIOS, N., CAVALLERI, J., Delvenne, P., Desmecht, D., ROUSSEAU, A.-F., & LAMBERMONT, B. (May 2022). Inflammation au cours de la COVID-19. Revue Médicale de Liège, 77 (5-6), 277-284. Peer reviewed |
 | Layios, N., Visée, C., Mistretta, V., Denooz, R., Maes, N., Descy, J., Frippiat, F., Marchand, S., & Grégoire, N. (2022). Modelled target attainment after temocillin treatment in severe pneumonia: systemic and epithelial lining fluid pharmacokinetics of continuous versus intermittent infusions. Antimicrobial Agents and Chemotherapy, 0205221. doi:10.1128/AAC.02052-21 Peer Reviewed verified by ORBi |
 | Gosset, C., FOGUENNE, J., SIMUL, M., TOMSIN, O., AMMAR, H., LAYIOS, N., MASSION, P., DAMAS, P., & GOTHOT, A. (13 October 2021). Machine learning identification of specific changes in myeloid cell phenotype during bloodstream infections. Scientific Reports, 11, 20288. doi:10.1038/s41598-021-99628-8 Peer Reviewed verified by ORBi |
 | GONCETTE, V., Layios, N., DESCY, J., & FRIPPIAT, F. (September 2021). Continuous infusion, therapeutic drug monitoring and outpatient parenteral antimicrobial therapy with ceftazidime/avibactam: a retrospective cohort study. Journal of Global Antimicrobial Resistance, 26, 15 - 19. doi:10.1016/j.jgar.2021.04.015 Peer Reviewed verified by ORBi |
 | LAMBERMONT, B., SEIDEL, L., THYS, M., CAVALLERI, J., DELANAYE, P., CANIVET, J.-L., KISOKA, G., LAYIOS, N., LEDOUX, D., MASSION, P., MORIMONT, P., Parzibut, G., PIRET, S., ROBINET, S., ROUSSEAU, A.-F., WIESEN, P., Chase, J. G., MEURIS, C., Moutschen, M., & Misset, B. (2021). Comparison of Covid-19 patient management and outcome in a tertiary care center during the first and second waves of the pandemic. Annals of Intensive Care, Suppl 1, 86. Peer Reviewed verified by ORBi |
 | Heilmann, E., Gregoriano, C., Annane, D., Reinhart, K., Bouadma, L., Wolff, M., Chastre, J., Luyt, C.-E., Tubach, F., Branche, A. R., Briel, M., Christ-Crain, M., Welte, T., Corti, C., de Jong, E., Nijsten, M., de Lange, D. W., van Oers, J. A. H., Beishuizen, A., ... Schuetz, P. (2021). Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trials. Age and Ageing, 50 (5), 1546-1556. doi:10.1093/ageing/afab078 Peer Reviewed verified by ORBi |
 | Lambermont, B., Seidel, L., THYS, M., CAVALLERI, J., Delanaye, P., Canivet, J.-L., KISOKA, G., Layios, N., & Misset, B. (2021). Comparison of Covid‐19 patient management and outcome in a tertiary care center during the first and second waves of the pandemic. Annals of Intensive Care. Peer Reviewed verified by ORBi |
 | DE VOEGHT, A., CALMES, D., BECK, F., SYLVESTRE, J.-B., DELVENNE, P., PETERS, P., VERTENOEIL, G., BARON, F., LAYIOS, N., & CANIVET, J.-L. (2020). Thrombotic microvascular injury is not mediated by thrombotic microangiopathy despite systemic complement activation in Covid-19 patients. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/256301. |
 | FRIPPIAT, F., Vercheval, C., & Layios, N. (2020). Meropenem: continuous or extended infusion? Critical care (London, England), 24 (1), 192. doi:10.1186/s13054-020-02883-w Peer reviewed |
 | Perot, A., Misset, B., MASSION, P., PIRET, S., ROUSSEAU, A.-F., WIESEN, P., ROBINET, S., LAMBERMONT, B., MORIMONT, P., LEDOUX, D., CANIVET, J.-L., & LAYIOS, N. (2020). Low incidence of thrombotic events in SARS-CoV-2 mechanically ventilated anticoagulated patients. Intensive Care Medicine Experimental, 8 (Suppl 2), 001583. Peer Reviewed verified by ORBi |
 | GONCETTE, V., Layios, N., & Frippiat, F. (2020). Continuous infusion and outpatient parenteral antimicrobial therapy with ceftazidime-avibactam: evaluation of efficacy based on therapeutic drug monitoring [Paper presentation]. ECCMID 2020. Peer reviewed |
 | Uyttendaele, V., Knopp, J. L., PIROTTE, M., BAYET, M., MORIMONT, P., LAYIOS, N., LAMBERMONT, B., Shaw, G. M., Chase, J. G., & Desaive, T. (2020). STAR-Liège: Modulating Insulin AND Nutrition Improves Glycaemic Control [Poster presentation]. e-ISICEM - International Symposium on Intensive Care & Emergency Medicine. |
 | LAMBERMONT, B., ERNST, M., DEMARET, P., BOCCAR, S., FRAIPONT, V., GURDEBEKE, C., VAN BRUSSEL, C., QUINONEZ, M., DUBOIS, C., LEMINEUR, T., NJAMBOU, T., AKANDO, B., WERTZ, D., THYS, M., MAES, N., CANIVET, J.-L., KISOKA, G., LAYIOS, N., LEDOUX, D., ... HIGNY, J. (2020). Corticosteroids are associated with a decrease in mortality in a multicenter cohort of mechanically ventilated COVID-19 patients [Poster presentation]. ESICM 2020. |
 | MARCHETTA, S., LAMBERMONT, B., MASSION, P., ROUSSEAU, A.-F., LAYIOS, N., ROBINET, S., CANIVET, J.-L., KISOKA, G., LEDOUX, D., MORIMONT, P., PIRET, S., WIESEN, P., & Misset, B. (2020). La première vague de la COVID-19 aux Soins intensifs. Revue Médicale de Liège. Peer reviewed |
 | Alessandri, C., & Layios, N. (2020). Actualités et guide pratique d'utilisation de la procalcitonine dans les bactériémies. Vaisseaux, Coeur, Poumons. Editorial reviewed |
 | LAMBERMONT, B., ERNST, M., DEMARET, P., FRAIPONT, V., GURDEBEKE, C., SOTTIAUX, T., QUINONEZ, M., DUBOIS, C., NJAMBOU, T., AKANDO, B., LEMINEUR, T., WERTZ, D., FORET, F., ROUSSEAU, A.-F., LEDOUX, D., LAYIOS, N., ROBINET, S., MORIMONT, P., & Misset, B. (2020). Corticosteroid therapy is associated with a decrease in mortality in a multicenter cohort of mechanically ventilated COVID-19 patients. Intensive Care Medicine Experimental, 8 (Suppl 2), 001357. Peer Reviewed verified by ORBi |
 | Skripkina, E., Canivet, A., Wautier, M., Martiny, D., Hallin, M., MEEX, C., & LAYIOS, N. (2019). Méningite à Campylobacter jejuni. Revue Médicale de Liège, 74 (7-8), 420-423. Peer reviewed |
 | Parzibut, G., CANIVET, J.-L., GUIOT, J., Lambermont, B., Layios, N., LEDOUX, D., Massion, P., MORIMONT, P., PIRET, S., ROBINET, S., Rousseau, A.-F., Verscheure, S., WIESEN, P., & Misset, B. (2019). Le syndrome de detresse respiratoire aigue. Revue Médicale de Liège, 74 (10), 514-520. Peer reviewed |
| MALAISE, O., & LAYIOS, N. (2018). Covid : pourquoi il ne faut pas brûler le tocilizumab ? Journal du Médecin. |
 | DESCY, J., VISEE, C., FRIPPIAT, F., MEEX, C., LAYIOS, N., VAN BAMBEKE, F., & MELIN, P. (21 April 2018). Temocillin susceptibility testing with Vitek2® system and E-test® Are these methods reliable to determine temocillin MIC ? [Poster presentation]. ECCMID 2018. |
 | Alves, J., Alp, E., Koulenti, D., Zhang, Z., Ehrmann, S., Blot, S., Bassetti, M., Conway-Morris, A., Reina, R., Teran, E., Sole-Lleonart, C., Ruiz-Rodríguez, M., Rello, J., SANEME-2 investigators, & Layios, N. (April 2018). Nebulization of antimicrobial agents in mechanically ventilated adults in 2017: an international cross-sectional survey. European Journal of Clinical Microbiology and Infectious Diseases, 37 (4), 785 - 794. doi:10.1007/s10096-017-3175-5 Peer Reviewed verified by ORBi |
 | Montague, S.* , Delierneux, C.* , LECUT, C., LAYIOS, N., Dinsdale, R., Lee, C., Poulter, N., Andrews, R., Hampson, P., Wearn, C., MAES, N., Bishop, J., Bamford, A., Gardiner, C., Lee, W., Iqbal, T., Moiemen, N., Watson, S., Oury, C.* , ... Gardiner, E.*. (February 2018). Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI. Blood, 2 (3), 240/251. doi:10.1182/bloodadvances.2017011171 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | LAYIOS, N., Delierneux, C., Hego, A., HUART, J., GOSSET, C., LECUT, C., MAES, N., Geurts, P., Joly, A., LANCELLOTTI, P., Albert, A., DAMAS, P., GOTHOT, A., & Oury, C. (December 2017). Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study. Intensive Care Medicine Experimental, 5 (1), 32. doi:10.1186/s40635-017-0145-2 Peer Reviewed verified by ORBi |
 | VISEE, C., LAYIOS, N., MISTRETTA, V., MAES, N., VAN BAMBEKE, F., & FRIPPIAT, F. (23 April 2017). Epithelial lining fluid penetration of temocillin administered by continuous infusion in critically ill patients with nosocomial pneumonia [Paper presentation]. 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienne, Austria. |
 | VISEE, C., FRIPPIAT, F., DESCY, J., MEEX, C., MELIN, P., MISTRETTA, V., VAN BAMBEKE, F., & LAYIOS, N. (22 April 2017). Are Vitek2 system and E-test relevant and reliable for determining susceptibility to temocillin? [Poster presentation]. 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienne, Austria. |
 | FRIPPIAT, F., VERCHEVAL, C., & LAYIOS, N. (01 February 2016). Decreased antibiotic consumption in the Belgian community: Is it credible? Clinical Infectious Diseases, 62 (3), 403-404. doi:10.1093/cid/civ868 Peer Reviewed verified by ORBi |
Delierneux, C., LAYIOS, N., Hego, A., HUART, J., Joly, A., Geurts, P., DAMAS, P., LECUT, C., GOTHOT, A., & Oury, C. (19 October 2015). Elevated basal levels of platelet-bound fibrinogen predict the occurrence of sepsis in ICU: a prospective study [Paper presentation]. Belgian Society on Thrombosis and Haemostasis (BSTH), Lamot, Belgium. |
Delierneux, C., LAYIOS, N., Hego, A., HUART, J., Joly, A., Geurts, P., DAMAS, P., LECUT, C., GOTHOT, A., & Oury, C. (23 June 2015). Prospective analysis of platelet activation markers to predict severe infection and mortality in intensive care units [Poster presentation]. XXV Congress of the International Society on Thrombosis and Haemostasis (ISTH), Toronto, Canada. |
 | HAYETTE, M.-P., WERY, M., BOREUX, R., PEETERS, S., STIRLING, E., STEVENSON, R., & LAYIOS, N. (25 April 2015). Evaluation of a commercially developed semi-automated PCR-surface enhanced raman scattering assay for the detection of Candida species in blood [Poster presentation]. ECCMID, Copenhagen, Denmark. |
 | ROUSSEAU, A.-F., & LAYIOS, N. (March 2015). Serum markers of sepsis in burn patients: it takes more to convince! Critical Care Medicine, 43 (3), 100-1. doi:10.1097/CCM.0000000000000815 Peer Reviewed verified by ORBi |
 | LAYIOS, N., Delierneux, C., Hego, A., HUART, J., Joly, A., Geurts, P., DAMAS, P., LECUT, C., Gothot, A., & Oury, C. (2015). Erratum: Elevated basal levels of circulating activated platelets predict ICU-acquired sepsis and mortality: a prospective study. Critical Care, 19 (1), 301. doi:10.1186/s13054-015-1005-7 Peer Reviewed verified by ORBi |
 | LAYIOS, N., GOSSET, C., Delierneux, C., Hego, A., HUART, J., Joly, A., Geurts, P., DAMAS, P., Oury, C., & Gothot, A. (2015). Erratum: Prospective immune profiling in critically ill adults: before, during and after severe sepsis and septic shock. Critical Care, 19 (1), 300. doi:10.1186/s13054-015-1006-6 Peer Reviewed verified by ORBi |
 | DAMAS, P., FRIPPIAT, F., ANCION, A., CANIVET, J.-L., LAMBERMONT, B., LAYIOS, N., MASSION, P., MORIMONT, P., NYS, M., PIRET, S., LANCELLOTTI, P., WIESEN, P., D'ORIO, V., SAMALEA SUAREZ, N., & LEDOUX, D. (January 2015). Prevention of ventilator-associated pneumonia and ventilator-associated conditions: A randomized controlled trial with subglottic secretion suctioning. Critical Care Medicine, 43 (1), 22-30. doi:10.1097/CCM.0000000000000674 Peer Reviewed verified by ORBi |
 | LAYIOS, N., GOSSET, C., Delierneux, C., Hego, A., HUART, J., DAMAS, P., Oury, C., & GOTHOT, A. (2015). Prospective immune profiling in critically ill adults : before, during and after severe sepsis shock. Critical Care, 19 (1). |
 | LAYIOS, N., CIUTEA, M., LONGUEVILLE, M., NYS, M., & DAMAS, P. (October 2014). Evaluation of Temocillin for treatment of nosocomial infections. Intensive Care Medicine, 40 (supplément 1), 194, (0704. Peer Reviewed verified by ORBi |
 | FRIPPIAT, F., Musuamba, F. T., Seidel, L., Albert, A., DENOOZ, R., Charlier, C., Van Bambeke, F., Wallemacq, P., DESCY, J., LAMBERMONT, B., LAYIOS, N., DAMAS, P., & Moutschen, M. (12 September 2014). Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study. Journal of Antimicrobial Chemotherapy, 70, 207-216. doi:10.1093/jac/dku354 Peer Reviewed verified by ORBi |
 | LAYIOS, N., & DAMAS, P. (May 2014). Epidemiology of VAP and VAC [Poster presentation]. 24th European Congress of Clinical Microbiology and Infectious Diseases. |
 | LAYIOS, N., CANIVET, J.-L., Baron, F., Moutschen, M., & Hayette, M.-P. (2014). Mortierella wolfii-Associated Invasive Disease. Emerging Infectious Diseases, 20 (9), 1591-2. doi:10.3201/eid2009.140469 Peer Reviewed verified by ORBi |
 | Frippiat, F., Seidel, L., Denooz, R., DAMAS, P., Layios, N., & Moutschen, M. (2014). Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration. Open Forum Infectious Diseases. doi:10.1093/ofid/ofu052 Peer Reviewed verified by ORBi |
 | GUNTZ, J., LAYIOS, N., & DAMAS, P. (2014). Catastrophic antiphospholipid syndrome : case reports and review of the literature. Acta Anaesthesiologica Belgica, 65, 87-94. Peer Reviewed verified by ORBi |
 | LAYIOS, N., HAYETTE, M.-P., HUWART, A., JOSKIN, J., BLETARD, N., BARON, F., & MOUTSCHEN, M. (September 2013). First report of Mortierella wolfii causing human disease [Poster presentation]. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). |
 | LAYIOS, N., HAYETTE, M.-P., HUWART, A., JOSKIN, J., BLETARD, N., BARON, F., & MOUTSCHEN, M. (September 2013). First report of Mortierella wolfii causing human disease [Paper presentation]. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). |
 | LAYIOS, N., & DAMAS, P. (2013). The authors reply. Critical Care Medicine, 41 (3), 28. doi:10.1097/CCM.0b013e31827c04b6 Peer Reviewed verified by ORBi |
 | DAMAS, P., & LAYIOS, N. (2013). The authors reply. Critical Care Medicine, 41 (2), 19. doi:10.1097/CCM.0b013e318275cba9 Peer Reviewed verified by ORBi |
 | LAYIOS, N., & LAMBERMONT, B. (2013). Procalcitonin for antibiotic treatment in intensive care unit patients. Current Infectious Disease Reports, 15 (5), 394-9. doi:10.1007/s11908-013-0360-2 Peer reviewed |
 | MARECHAL, H., LAYIOS, N., & DAMAS, P. (2013). The severity of ICU-acquired pneumonia. Current Infectious Disease Reports, 15 (5), 380-384. doi:10.1007/s11908-013-0359-8 |
| ANCION, A., LAYIOS, N., NYS, M., VERCHEVAL, C., & DAMAS, P. (2012). Antibiotic therapy and outcome in ICU [Paper presentation]. Congrès de la SIZ. |
 | LAYIOS, N., & DAMAS, P. (2012). Les prélèvements microbiologiques ont-ils encore une place dans le diagnostic de pneumopathie acquise sous ventilation mécanique ? Réanimation, 21, 3-8. doi:10.1007/s13546-011-0337-9 Peer Reviewed verified by ORBi |
 | LAYIOS, N., LAMBERMONT, B., CANIVET, J.-L., MORIMONT, P., PREISER, J.-C., GARWEG, C., LEDOUX, D., FRIPPIAT, F., PIRET, S., GIOT, J.-B., WIESEN, P., MEURIS, C., MASSION, P., LEONARD, P., NYS, M., LANCELLOTTI, P., CHAPELLE, J.-P., & DAMAS, P. (2012). Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Critical Care Medicine, 40 (8), 2304-9. doi:10.1097/CCM.0b013e318251517a Peer Reviewed verified by ORBi |
 | DAMAS, P., LAYIOS, N., SEIDEL, L., NYS, M., MELIN, P., & LEDOUX, D. (July 2011). Severity of ICU-acquired pneumonia according to infectious microorganisms. Intensive Care Medicine, 37 (7), 1128-35. doi:10.1007/s00134-011-2255-8 Peer Reviewed verified by ORBi |
 | LAYIOS, N., LAMBERMONT, B., LEDOUX, D., MORIMONT, P., MASSION, P., GARWEG, C., FRIPPIAT, F., NYS, M., CHAPELLE, J.-P., & DAMAS, P. (2009). Usefulness of procalcitonin for the decision of antibiotic treatment in ICU patients. Intensive Care Medicine, 35 (Suppl 1), 82. Peer Reviewed verified by ORBi |
 | LAYIOS, N. (2009). La décontamination digestive sélective: vieux démons ou .... jeune fiancée? Réanimation, 18, 467-469. doi:10.1016/j.reaurg.2009.06.007 Peer Reviewed verified by ORBi |
| MICHIELS, G., WIESEN, P., LAYIOS, N., NYS, M., & DAMAS, P. (20 June 2008). Renal failure and ICU-acquired infection [Paper presentation]. Spring Meeting de la Société Belge de Médecine Intensive (SIZ). |
| BROUSSE, M., LAYIOS, N., LEDOUX, D., NYS, M., & DAMAS, P. (2008). Pseudomonas aeruginosa and severity of ventilator associated pneumonia [Paper presentation]. Spring Meeting de la Société Belge de Médecine Intensive (SIZ). |
 | WIESEN, P., LAYIOS, N., NYS, M., & DAMAS, P. (2008). Renal failure and ICU-acquired infection. Intensive Care Medicine, 34 (Suppl 1), 265(0864. Peer Reviewed verified by ORBi |
| LAYIOS, N., LEDOUX, D., NYS, M., & DAMAS, P. (2008). Pseudomonas aeruginosa and severity of ventilator-associated pneumonia [Poster presentation]. 21st Annual Congress of the European Society of Intensive Care Medicine. |
 | LAYIOS, N., LEDOUX, D., NYS, M., & DAMAS, P. (2008). Pseudomonas aeruginosa and severity of ventilator associated pneumonia. Intensive Care Medicine, 34 (Suppl 1), 38. Peer Reviewed verified by ORBi |
 | Grosu, I., Ghekiere, O., LAYIOS, N., Hantson, P., & Cosnard, G. (2007). Toxoplasma encephalitis after autologous stem cell transplantation. Leukemia and Lymphoma, 48 (1), 201-3. doi:10.1080/10428190601011564 Peer Reviewed verified by ORBi |
 | Boland, C., LAYIOS, N., Ferrant, A., Waignein, F., Theate, I., & Hantson, P. (2006). Relapsing T-cell lymphoma mimicking adult respiratory distress syndrome and sepsis. Leukemia and Lymphoma, 47 (9), 1989-90. doi:10.1080/10428190600687893 Peer Reviewed verified by ORBi |
 | Van Den Neste, E., Michaux, L., LAYIOS, N., Costantini, S., Francart, J., Lambert, C., Sonet, A., André, M., Robert, A., & Ferrant, A. (2004). High incidence of complications after 2-chloro-2'-deoxyadenosine combined with cyclophosphamide in patients with advanced lymphoproliferative malignancies. Annals of Hematology, 83 (6), 356-63. doi:10.1007/s00277-004-0858-7 Peer Reviewed verified by ORBi |
 | LAYIOS, N., Van Den Neste, E., Jost, E., Deneys, V., Scheiff, J. M., & Ferrant, A. (2001). Remission of severe cold agglutinin disease after Rituximab therapy. Leukemia, 15 (1), 187-8. doi:10.1038/sj.leu.2401976 Peer Reviewed verified by ORBi |
